Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Immunotherapy|July 15, 2011
Use of monoclonal antibodies in renal transplantationMartijn W F van den Hoogen, Luuk B Hilbrands
Expert Opinion on Biological Therapy|May 16, 2012
Anti-T-cell antibodies for the treatment of acute rejection after renal transplantationMartijn W F van den Hoogen, Andries J Hoitsma, Luuk B Hilbrands
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|February 26, 2013
Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitorsMartijn W F van den Hoogen, Anna M van der Hoeven, Luuk B Hilbrands
Drugs|November 22, 2019
Costimulation Blockade in Kidney Transplant RecipientsMarieke van der Zwan, Dennis A Hesselink, Martijn W F van den Hoogen, et al.
Transplantation Direct|April 14, 2017
Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical OutcomeMartijn W F van den Hoogen, Eric J Steenbergen, Marije C Baas, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 17, 2019
Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug UsersMohammad Bakhriansyah, Patrick C Souverein, Martijn W F van den Hoogen, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 10, 2012
[Reimbursement for alternative medical treatment in the Netherlands, incomprehensible]Martijn W F van den Hoogen, Calin Popa, Lammy D Elving, et al.
Thrombosis Research|August 16, 2008
Use of the platelet function analyzer to minimize bleeding complications after renal biopsyMartijn W F van den Hoogen, Bert W Verbruggen, Robert Polenewen, et al.
Blood Purification|May 6, 2019
Successful Treatment of Severe Hyperammonaemia with Ultra-High Dose Continuous Veno-Venous HaemodiafiltrationDirk P Boer, Sarah L Mourik, Martijn W F van den Hoogen, et al.
Plos One|November 14, 2014
Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapyElena G Kamburova, Hans J P M Koenen, Martijn W F van den Hoogen, et al.
Pageof 3